Home
HelpTest Code TRPS Troponin T, 5th Generation, Plasma
Specimen Required
Collection Container/Tube:
Preferred: Light-green top (lithium heparin gel)
Acceptable: Green top (lithium heparin)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. Lithium heparin gel tubes should be centrifuged within 2 hours of collection.
2. Plasma from lithium heparin tubes should be centrifuged and aliquoted into a plastic vial within 2 hours of collection.
Useful For
Aiding in the exclusion of the diagnosis of acute coronary syndrome in a single plasma specimen
Aiding in the diagnosis of acute coronary syndrome
Monitoring acute coronary syndromes and estimating prognosis
Possible utility in monitoring patients with nonischemic causes of cardiac injury
Method Name
Electrochemiluminescent Immunoassay (ECLIA)
Reporting Name
Troponin T, 5th gen, PSpecimen Type
Plasma Li HeparinSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Plasma Li Heparin | Frozen (preferred) | 365 days | |
| Ambient | 24 hours | ||
| Refrigerated | 24 hours |
Reject Due To
| Gross hemolysis | Reject |
| Gross lipemia | OK |
| Gross icterus | OK |
Clinical Information
Troponin T is a myofibrillar protein found in striated musculature. There are 2 types of myofilament: a thick filament containing myosin and a thin filament consisting of 3 different proteins, namely actin, tropomyosin, and troponin. Troponin is itself a complex of 3 protein subunits, which are termed troponin T, troponin I, and troponin C:
-Troponin T binds the troponin complex to tropomyosin
-Troponin I inhibits actomyosin ATPase in relation to the calcium concentration
-Troponin C has 4 binding sites for calcium and mediates calcium dependency
Troponin T is found in free cytosol and structurally bound protein. The unbound pool of troponin T is the source of early protein release in myocardial damage. Troponin T is released from the structural elements at a later stage, corresponding to the degradation of myofibrils that occurs in irreversible myocardial damage. Troponin T becomes elevated 2 to 4 hours after the onset of myocardial necrosis and can remain elevated for up to 14 days, or even longer on occasion.
The most common cause of cardiac injury is myocardial ischemia (ie, acute myocardial infarction). These patients are known to have an adverse short- and long-term prognosis compared to patients with unstable angina and no elevation of troponin T. Many of these patients, especially those with troponin T elevations above 30 ng/L, benefit from an aggressive strategy with anticoagulation and an invasive interventional strategy.
Reference Values
Males: ≤15 ng/L
Females: ≤10 ng/L
Interpretation
Values for healthy adults, based upon available literature and clinical guidelines, are 10 ng/L or less for women and 15 ng/L or less for men.
For patients who present with suspected acute coronary syndromes, troponin T values greater than the reference interval with a rising (≥10 ng/L over 2 hours or ≥12 ng/L over 6 hours) pattern are highly suggestive of acute cardiac injury. Decreasing values are indicative of recent cardiac injury. Serial measurement is highly recommended for the diagnosis or exclusion of acute coronary syndromes.
Troponin T values greater than the reference interval are associated with adverse events in patients with ischemic heart disease and many other clinical situations. Clinical judgment is necessary to distinguish patients who have ischemic heart disease from those who do not.
Cautions
As with all markers of cardiac injury, elevations of cardiac troponin T (cTnT) do not in and of themselves indicate the presence of an ischemic mechanism. Many other disease states can be associated with elevations of cTnT via mechanisms different from those that cause injury in patients with acute coronary syndromes. These include trauma including contusion, ablation, and pacing; congestive heart failure; pulmonary embolism; kidney failure; and myocarditis.
Method Description
The cobas e immunoassay Troponin T Gen 5 method employs 2 monoclonal antibodies specifically directed against human cardiac troponin T. A biotinylated monoclonal antibody and a second monoclonal antibody labeled with a ruthenium complex react with troponin T to form a sandwich complex. After the addition of streptavidin-coated microparticles, the complex becomes bound to the solid phase via interaction of biotin and streptavidin. The reaction mixture is aspirated into the measuring cell where the microparticles are magnetically captured onto the surface of the electrode. Application of a voltage to the electrode then induces chemiluminescent emission which is measured by a photomultiplier.(Package insert: Elecsys Troponin T Gen 5. Roche Diagnostics; V1, 10/2021)
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 dayPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
84484
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| TRPS | Troponin T, 5th gen, P | 67151-1 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| TRPS | Troponin T, 5th gen, P | 67151-1 |